◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›EDIT

EDIT (EDIT)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

Zacks·vor 40 Tagen

Why Is Editas (EDIT) Down 12.4% Since Last Earnings Report?

Motley Fool·vor 44 Tagen

CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?

GlobeNewswire·vor 47 Tagen

Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference

MT Newswires·vor 49 Tagen

Editas Medicine Prices Public Offering of Shares, Warrants

GlobeNewswire·vor 49 Tagen

Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering

MT Newswires·vor 50 Tagen

Editas Medicine Proposes Public Stock Offering; Shares Fall Pre-Bell

Frag BlackSpecter AI über EDIT

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist EDIT kaufenswert?EDIT Earnings Analyse EDIT Bewertung

AI Chat öffnen →